SCHEMBL5329147

SCHEMBL5329147

COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(OC)c(O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
USP2 O75604 2/20 0.62
MAPK1 P28482 1/20 0.62
RAB9A P51151 1/20 0.62
GAA P10253 10/20 0.57
POLB P06746 5/20 0.56
MAPT P10636 4/20 0.55
KMT2A Q03164 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
LMNA P02545 1/20 0.52
KDM4E B2RXH2 6/20 0.51
HSD17B10 Q99714 3/20 0.51
CASP1 P29466 2/20 0.51
TSHR P16473 1/20 0.51
CASP7 P55210 1/20 0.51
MEN1 O00255 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
HTT P42858 1/20 0.48
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5332856 0.92 ALDH1A1 (0.74) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5341434 0.91 GAA (0.67) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5477271 0.90 ALDH1A1 (0.65) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5480584 0.90 ALDH1A1 (0.60) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL3323323 0.90 ALDH1A1 (0.63) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5335764 0.89 ALDH1A1 (0.66) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5479741 0.89 ALDH1A1 (0.57) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5333682 0.89 ALDH1A1 (0.57) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5338272 0.89 ALDH1A1 (0.63) ALDH1A1USP2MAPK1RAB9AGAA
SCHEMBL5330946 0.88 ALDH1A1 (0.60) ALDH1A1USP2MAPK1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112015-A1 Substituted dihydropyridines and methods of use C3AR1, C5AR1, C5AR2 ALDH1A1 1488/4885USP2 4362/4885MAPK1 4425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.